Skip to content

Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial

Comparing the Reconstruction of the Orbit Fracture With a Poly Caprolactone / Tri-Calcium Phosphate ( PCL/TCP ) Implant vs. a Titanium Mesh Implant.

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01119144
Acronym
PCL/TCP
Enrollment
80
Registered
2010-05-07
Start date
2010-04-30
Completion date
2015-03-31
Last updated
2014-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fractures, Enophthalmos, Diplopia

Keywords

Orbital, fractures, enophthalmos, diplopia, eye

Brief summary

Hypothesis: Polycaprolactone / Tricalcium Phosphate Orbital (PCL / TCP) Implant is as effective in the reconstruction of the Orbital walls as Titanium Mesh implant. In this study we will be conducting a randomised trial to compare implants made of 2 materials for Orbital reconstruction * Polycaprolactone / Tricalcium Phosphate (PCL / TCP) * Titanium Patients to be recruited : * 80 randomised equally into the 2 groups * age range: 21 - 70 * includes orbital wall defects from trauma, after osteotomies * excludes patients with Diabetes Mellitus, known allergies to polycaprolactone & its analogues, know allergies to Tricalcium Phosphate & its analogues, infections generalised & around the orbital region Trial Duration: April 2010 - March 2015 Follow up: * postoperative 1 week, 1 month, 3 months, 6 months, and 12 months * Computer Tomographic (CT) scan of Orbits immediate postoperative and at 12 months appointment

Detailed description

Hypothesis: Polycaprolactone / Tricalcium Phosphate (PCL / TCP) Orbital Implant is as effective in the reconstruction of the Orbital walls as Titanium Mesh In this study we will be conducting a randomised trial to compare implants made of 2 materials for Orbital reconstruction * Polycaprolactone / Tricalcium Phosphate (PCL / TCP) * Titanium Patients to be recruited : * 80 randomised equally into the 2 groups * age range: 21 -70 * includes orbital wall defects from trauma confirmed by Computer Tomographic (CT) scans, after osteotomies * excludes patients with Diabetes Mellitus, known allergies to polycaprolactone & its analogues, know allergies to Tricalcium Phosphate & its analogues, infections generalised & around the orbital region Trial Duration : April 2010 - March 2015 Follow up: * postoperative 1 week, 1 month, 3 months, 6 months, and 12 months * Computer Tomographic (CT) scan of Orbits immediate postoperative and at 12 months appointment * all patients will be seen & assessed in the Plastic & Ophthalmology outpatient clinics by Principal Investigator (PI) and collaborators End point : * endpoint for follow-up is 12 months * all patients are assessed for assessed for diplopia, enophthalmos, exophthalmos, visual acuity, mobility of the globe, contour symmetry * all patients will have a Computer Tomographic (CT) scan of the orbits at 12 months to assess the bony orbit & orbital volume * patients will be discharged from follow up at 12 months if asymptomatic * patients with complications will exit the protocol & will be treated on their merits eg. infection - removal of implant, etc Data Management : * maintained by the Principal Investigator (PI) under repository of the Research & Development Office, National Healthcare Group (NHG) / National University Health Systems (NUHS), Singapore * no data will be released without the permission of the Principal Investigator (PI) & the Research & Development Office, National Healthcare Group (NHG) / National University Health Systems (NUHS), Singapore

Interventions

DEVICEPolycaprolactone / Tri-Calcium Phosphate

Orbital implant for reconstruction of the orbital walls

Titanium mesh for comparison to Polycaprolactone / Tri-Calcium Phosphate (PCL / TCP) mesh

Sponsors

National University Hospital, Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* age 21 y - 70 y * both males / females included * orbital fractures * defect after orbital osteotomies

Exclusion criteria

* patient refusal * infection around the orbit / generalised infection * Diabetes mellitus * allergies to polycaprolactone & its analogues * allergies to titanium

Design outcomes

Primary

MeasureTime frameDescription
Enophthalmos1 yearAssess the presence of enophthalmos after reconstruction of the orbital walls at 1 week, 1 month, 3 months, 6 months and 12 months

Secondary

MeasureTime frameDescription
Diplopia1 yearAssess the evidence of diplopia on follow up at 1 week, 1 month, 3 months, 6 months and 12 months
motility of the globe1 yearassess globe motility on follow up at 1 week, 1 month, 3 months, 6 months, and 12 months

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026